18 天前 - … Adjuvant osimertinib administered over a 3-year period in patients diagnosed
with stage IB–IIIA non-small cell lung cancer (NSCLC) and epidermal growth factor receptor (…

26 天前 - … can facilitate diagnosis, guide treatment selection, … adjuvant treatment has yet to
be shown. A potentially meaningful clinical application of cfDNA analysis is adjuvant treatment …

63 天前 - … adjuvant immunotherapy with Nivolumab who presented to dermatology for
evaluation … While the differential diagnosis of SD typically includes psoriasis, atopic and contact …

109 天前 - … and subsequent systemic therapy, PDAC often recurs. Additionally, most patients
present with locally advanced and unresectable tumors at the time of diagnosis. Cancer-…

162 天前 - … and included both adenocarcinomas and predominantly squamous cell carcinomas.
There was no survival benefit shown by neoadjuvant therapy. A subgroup‐analysis of SCC …

229 天前 - Background: Recent international guidelines recommend treatment without antibiotics
for uncomplicated diverticulitis (UD). We assessed physicians’ current knowledge and …

280 天前 - … (L)-1 inhibitors in neo-adjuvant/adjuvant settings is crucial. Research has shown
that … tumor types for patients diagnosed with an early-stage cancer. We developed a health …

284 天前 - … patients (stage IB-IIIB) diagnosed … treatment options for elderly patients with
advanced LSCC remain limited. For these patients, postoperative cisplatin-based adjuvant therapy …

341 天前 - … Study design and study population This study enrolled 24,120 patients diagnosed
with … more severe underlying pathology in patients with adjuvant treatment and the radiation-…

358 天前 - … risk group allocation and adjuvant treatment decision-making … the mobile app on
all relevant issues of diagnosis and … of treatment and of not applying any adjuvant treatment. If …